PRPH: ProPhase Labs, Inc. Common Stock (DE) Company Profile & Statistics

ProPhase Labs, Inc. Common Stock (DE) Profile

Info & Links

CEO

Ted Karkus

Headquarters

711 STEWART AVE, SUITE 200
GARDEN CITY, NY 11530, UNITED STATES

Auditor

Morison Cogen

Share holders

147

Employees

ProPhase Labs, Inc. Common Stock (DE) Statistics

Valuation Measures

Market Capitalization²

14.62M

Enterprise Value

21.83M

Enterprise Value/EBITDA(ttm)

-0.95

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

Price to Book(mrq)

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

-1.77%

Operating Margin(ttm)

Profit Margin(ttm)

3567.02%

Return on Equity(ttm)

Return on Invested Capital(ttm)

-215.94%

Return on Assets(ttm)

Income Statement

Revenue(ttm)

5.59M

Revenue Per Share(ttm)

0.13

Gross Profit(ttm)

1.32M

EBITDA(ttm)³

-23.04M

Net Income Available to Common(ttm)

-41.45M

Diluted EPS(ttm)

Share Statistics

Beta (5Y Monthly)

52-Week Change

-86.41%

S&P 500 52-Week Change

17.58%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding¹

41.54M

Dividend Yield

Float⁴

% Held by Insiders

% Held by Institutions

Balance Sheet

Total Cash(mrq)

171.00K

Total Cash Per Share(mrq)

0.00

Total Debt(mrq)

7.38M

Total Debt/Equity(mrq)

64.49%

Current Ratio(mrq)

0.96%

Quick Ratio(mrq)

Book Value Per Share(mrq)

0.28

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.09

Free Cash Flow(ytd)

-3.51M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

PRPH

ProPhase Labs, Inc. Common Stock (DE)